Tryptophan metabolites promote the progression of pulmonary fibrosis by activating the mTOR/S6 pathway, while modulation of certain microbial communities may slow down fibrosis by inhibiting these pathways (Li et al., 2024). This evidence concerns the gene MTOR and pulmonary fibrosis.